Moderna coronavirus vaccine trial shows promising early results

1:21pm PDT - May 18th, 2020    moderna - The Globe And Mail

Eaight healthy volunteers, ages 18 to 55, made antibodies that were then tested in infected cells in the lab and were able to stop the virus from replicating — the key requirement for an effective vaccine